System.One — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

Labgeniustxlabgeniustx.com in 𝕏Oct 2017

LabGenius develops EVA, an automated antibody discovery platform that uses machine learning and automation to identify and co-optimize complex therapeutic antibodies such as multispecifics.

AI & Machine LearningBiotechDeep TechLondon

Harrison Rickerby(Executive Officer, Director)

BoardJames Field(Founder)in

Co-investorsAcequia Capital (AceCap)Atomico Backed Beast Ventures Champion Hill Ventures Gaingels +9 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.